Your email has been successfully added to our mailing list.

×
0.00773809523809518 0.00654761904761901 0.0238095238095237 0.0297619047619048 0.0714285714285714 0.030357142857143 0.0357142857142858 0.0357142857142858
Stock impact report

Potential coronavirus treatment touted by Trump already in shortage, pharmacists say [Reuters (UK)]

MYLAN NV ORDINARY SHARES (MYL) 
Last mylan nv ordinary shares earnings: 2/27 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.mylan.com/investor-relations
Company Research Source: Reuters
Potential coronavirus treatment touted by Trump already in shortage - pharmacists - Reuters 4 Min Read NEW YORK (Reuters) - An old malaria treatment that has been tried with some success against the new coronavirus and was touted by U.S. President Donald Trump at a news briefing earlier on Thursday is in short supply as demand surges amid the fast-spreading outbreak. The American Society of Health-System Pharmacists (ASHP), which maintains a list of drugs in shortage independent of the U.S. Food and Drug Administration’s list, added the generic malaria drug hydroxychloroquine to its list on Thursday. Four out of eight manufacturers of the drug are currently in shortage, it said. The new coronavirus, which causes the highly contagious COVID-19 respiratory illness, emerged in December in Wuhan, China and has spread throughout the world. There are currently no vaccines or treatments approved for the disease, but researchers are studying existing treatments and working on experimental one Show less Read more
Impact Snapshot
Event Time:
MYL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for MYL alerts
Opt-in for
MYL alerts

from News Quantified
Opt-in for
MYL alerts

from News Quantified